Literature DB >> 9605782

NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.

E R Heerdink1, H G Leufkens, R M Herings, J P Ottervanger, B H Stricker, A Bakker.   

Abstract

BACKGROUND: Both diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used, in particular among the elderly. The use of NSAIDs may decrease the efficacy of diuretics and induce congestive heart failure (CHF) in patients treated with diuretics.
OBJECTIVE: To investigate the risk of CHF associated with combined use of diuretics and NSAIDs in patients older than 55 years.
METHODS: We conducted a study in a base cohort of 10,519 recipients of diuretics and NSAIDs identified in the PHARMO database during the period from 1986 through 1992. The incidence density of hospitalizations for CHF during exposure to both diuretics and NSAIDs (index) was compared with that during exposure to diuretics only (reference).
RESULTS: We found an overall increased risk of hospitalization for CHF during periods of concomitant use of diuretics and NSAIDs compared with use of diuretics only (crude relative risk, 2.2; 95% confidence interval, 1.7-2.9). After adjusting for cofactors including age, sex, history of hospitalization, and drug use, a 2-fold increased risk remained (relative risk, 1.8; 95% confidence interval, 1.4-2.4).
CONCLUSION: Use of NSAIDs in elderly patients taking diuretics is associated with a 2-fold increased risk of hospitalization for CHF, especially in those with existing serious CHF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605782     DOI: 10.1001/archinte.158.10.1108

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  39 in total

Review 1.  Heart failure: Part II.

Authors:  M S Wilkes; H Middlekauff; J R Hoffman
Journal:  West J Med       Date:  1999-06

Review 2.  [Aging and water metabolism in health and illness].

Authors:  M Miller
Journal:  Z Gerontol Geriatr       Date:  1999-07       Impact factor: 1.281

Review 3.  Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.

Authors:  C Patrono; P Patrignani; L A García Rodríguez
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

4.  Implementing pharmacy practice research programs for the management of heart failure.

Authors:  Michael D Murray
Journal:  Pharm World Sci       Date:  2010-10

5.  Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly.

Authors:  Kathrine F Vandraas; Olav Spigset; Milada Mahic; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2010-04-20       Impact factor: 2.953

6.  Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community.

Authors:  Arduino A Mangoni; Richard J Woodman; Paraskevi Gaganis; Andrew L Gilbert; Kathleen M Knights
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

Review 7.  Understanding the NSAID related risk of vascular events.

Authors:  Harald E Vonkeman; Jacobus R B J Brouwers; Mart A F J van de Laar
Journal:  BMJ       Date:  2006-04-15

Review 8.  Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Authors:  Irmgard Tegeder; Gerd Geisslinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-04       Impact factor: 3.000

Review 9.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

10.  Use of anti-depressants and the risk of fracture of the hip or femur.

Authors:  M W M van den Brand; S Pouwels; M M Samson; T P van Staa; B Thio; C Cooper; H G M Leufkens; A C G Egberts; H J J Verhaar; F de Vries
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.